Men who have aggressive (high-risk), advanced or metastatic prostate cancer are commonly prescribed hormonal therapy drugs called, gonadotropin-releasing hormone (GnRH) agonists that suppress the growth of prostate cancer cells by inhibiting the ...
[Read More]